3PO
Axon 2175
CAS [18550-98-6]
MF C13H10N2OMW 210.23
- Purity:99%
- Soluble in DMSO
Description
Inhibitor of HIF-1-induced PFKFB3, an enzyme with a key role in glycolysis. Potential application as suppressor of tumor glucose metabolism and growth of non-small cell lung cancer cells. The PFKFB3 family member has the highest kinase:bisphosphatase ratio (740:1) of the four known PFKFB family members. 3PO markedly attenuated the stimulation of F2,6BP synthesis, 2-[1-14C]-deoxy-D-glucose uptake, lactate secretion, TNF-α secretion and T cell aggregation and proliferation.
KEYWORDS: 3PO | supplier | PFKFB3 inhibitor | 3PO | 3PO | CAS [18550-98-6] | Fructose 6-phosphate | PFKFB3 | F6P | F2 | 6BP | Inhibitor | Enzymes
| S Telang et al. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation. J. Trans. Med. 2012, 10, 95. |
| B Clem et al. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol. Cancer. Ther. 2008, 7, 110-120. |
- Certificate of Analysis
- Material Safety Data Sheet
Chemical name
(E)-3-(pyridin-3-yl)-1-(pyridin-4-yl)prop-2-en-1-one
Parent CAS No.
[18550-98-6]
Axon Medchem的业务之一，是独有的Axon Ligands配体库，在世界范围内，被认为是药物研发的标准。这其中，针对850余种生物靶标（包括细胞信号、基因转录、凋亡、细胞周期调控、CNS等），Axon Medchem拥有多达2000余种小分子抑制剂或调节剂。除了配体库，Axon Medchem还是欧洲著名的CRO公司，主要针对生物活性分子和药物类似分子展开合成及协议开发工作，在过去的10年中，Axon Medchem已经发现了多种潜在药物分子，并在生物医药界享有一定的声誉。
暂无问答
本网站将在规定时间内给予删除等相关处理。
